Who is sponsoring NCT05808855?

NCT05808855 is sponsored by University of Split, School of Medicine.

What drugs are being tested in NCT05808855?

Interventions in NCT05808855: two-component skin adhesive Glubran Tiss 2®, skin stitched with transcutaneous nylon suture.

What condition does NCT05808855 study?

NCT05808855 studies Carpal Tunnel Syndrome Bilateral.

Is NCT05808855 still recruiting?

NCT05808855 is currently completed. Last updated 27 November 2023.

Last reviewed 2023-11-27 · How we verify

NCT05808855

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurological Outcomes Following Carpal Tunnel Wound-closure Techniques

Completed NA Last updated 27 November 2023

What this trial tests

NA trial testing two-component skin adhesive Glubran Tiss 2® in Carpal Tunnel Syndrome Bilateral in 100 participants. Completed in 1 October 2023.

Timeline

1 May 2023

Primary endpoint
1 August 2023

1 October 2023

Quick facts

Lead sponsor	University of Split, School of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	1 May 2023
Primary completion	1 August 2023
Estimated completion	1 October 2023
Sites	2 locations across Croatia

Drugs / interventions tested

two-component skin adhesive Glubran Tiss 2®
skin stitched with transcutaneous nylon suture

Conditions studied

Carpal Tunnel Syndrome Bilateral — all drugs for Carpal Tunnel Syndrome Bilateral →

Sponsor

University of Split, School of Medicine

Who can join

Adults 18 to 99, any sex, with Carpal Tunnel Syndrome Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

single-centre randomised prospective trial will conducted at the University Hospital of Split in Croatia. The investigators plan to enrol 100 patients, randomly assigned to suture-based wound closure (n=50) or tissue adhesive-based wound closure (n=50) with two-component skin adhesive Glubran Tiss 2®. The neurological outcomes will assessed postoperatively during the follow-up period at intervals of 2, 6, and 12 weeks respectively.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Influence of Wound Closure Techniques after Surgical Decompression in Patients with Carpal Tunnel Syndrome on Sleep Disturbance and Life Quality: A Prospective Comparison of Surgical Techniques.
Sunjic Roguljic V, Roguljic L, Jukic I, Kovacic V. · · 2024 · cited 2× · PMID 38666800 · DOI 10.3390/clinpract14020042
The Influence of the Tissue Adhesive Material as a Surgical Wound-Closure Technique Following Carpal Tunnel Decompression on Neurological and Functional Outcomes: A Single-Center Randomized Controlled Trial.
Sunjic Roguljic V, Roguljic L, Kovacic V, Bilic I, et al · · 2024 · PMID 38435874 · DOI 10.7759/cureus.53312

Verify or expand the search:

Other University of Split, School of Medicine trials

Trials by the same sponsor.

NCT07286487 — Glycyrrhetinic Acid and Acute Irritant Dermatitis · NA · not yet recruiting
NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
NCT07140107 — Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews · NA · enrolling by invitation
NCT07078474 — Comparison of Skin Condition After Hyaluronic Acid Application on Dry vs. Moist Skin · NA · completed
NCT07079371 — Micellar Water and the Skin Barrier: Comparing Rinsing vs. Non-Rinsing Application · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05808855 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Split, School of Medicine
Last refreshed: 27 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05808855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing